Gross-to-Net Consulting Services

Transform Revenue Complexity into a Strategic Advantage 

With complex pricing structures, multiple market segments, and various discounts, your ability to forecast net revenue accurately is not just a finance function — it’s your competitive advantage. 

Argano helps pharmaceutical, biotech, and medical device companies navigate the intricacies of commercial rebates, chargebacks, government discounts, and returns — and move more quickly to profitability. 

Argano’s GTN edge

We start with the business problem, not the platform. We understand your revenue operations, your contracting complexity, and your margins — then align the right technology to protect them. The result is high-performance revenue operations: better decisions, stronger margins, and measurable impacts to your bottom line. 

Forecast with confidence

Model utilization and discounting by market segment, starting at the contract level — and improve your ability to predict net revenue in future periods, not just explain the last one.

Optimize accruals

Quantitatively assess the discounts flowing through each contract component and channel, enabling improved accrual accuracy, better informed reserves, and immediate bottom-line impact. 

Protect your margins

Identify and close the gaps where revenue disappears — miscalculated rebates, delayed chargeback processing, uncollected wholesaler fees — before they compound across quarters. 

Speed compliance

Ensure calculation methodologies align strictly with statutory guidelines and government pricing programs, including Medicaid Rebates, Medicare Part D coverage gaps, and the 340B Drug Pricing Program — with audit-defensible precision from day one. 

Automate and optimize

Move beyond fragmented spreadsheets and legacy software. We integrate and optimize platforms to automate calculations, reduce manual errors, and deliver value 6–12 months faster than traditional system integrators. 

Align the enterprise

GTN touches finance, commercial operations, legal, and more. Argano bridges the gaps between departments — removing silos and aligning workflows, data, and assumptions around a single, connected view of revenue. 

WHITEPAPER

Visibility Is Now Velocity: Gross–to–Net in Pharma’s New Era

See GTN Risk Before It Hits Your Earnings.

Download eBook

GTN expertise across pharma and other critical markets 

Argano’s life sciences practice drives high-performance operations across pharmaceuticals, biotechnology, medical devices, and more. Our GTN modeling capabilities serve organizations from emerging biotechs to large global pharma. 

Medical Devices & Diagnostics

Navigate complex pricing agreements, contracts, and rebate structures with specialized GTN strategies. Argano unifies disparate commercial data to streamline chargeback processing, reduce revenue leakage, and enhance forecasting accuracy across complex distribution channels, accelerating profitability while maintaining rigorous compliance.

Pharmaceuticals & Biotechnology

Optimize commercialization and safeguard revenue through advanced GTN modeling and automated accrual management. Argano modernizes revenue operations with audit-defensible precision, helping organizations navigate complex rebates, discounts, and government pricing mandates, unifying fragmented financial data to drive sharper forecasting and scalable profitability.

CLIENT STORIES

Transforming forecasting for greater precision and agility

Find out how a leading pharmaceutical manufacturer enhanced forecasting accuracy and agility to build a foundation for continued growth.

Learn More

Unified GTN performance management

True GTN management requires more than static calculations — it demands a dynamic operational engine. 

Our EPM solution bridges the gap between GTN complexity and enterprise-wide financial planning, giving you the platform you need to forecast with confidence, optimize accruals, and turn revenue data into strategic clarity. Built on proven platforms like Anaplan and Oracle EPM, we configure your GTN logic for the unique nuances of pharma, biotech, and medtech revenue operations. 

  • Connected GTN Model — Translate complex GTN mechanics into a single, connected model that links contracts, channels, and market segments — replacing top-down percentage estimates with bottom-up, driver-based forecasting. 

  • Real-Time Visibility — Move from end-of-month spreadsheet reconciliation to real-time EPM dashboards that track GTN accrual status, discount utilization, and net revenue trends as they happen. 

  • Scenario Planning — Model the financial impact of price changes, rebate adjustments, and contract renegotiations before they happen — giving leadership quantified confidence in their GTN projections. 

  • Scalable Architecture — From emerging biotech to global pharma, leverage an EPM platform that scales with your portfolio, data volumes, and GTN contracting complexity — without the rebuilds that spreadsheets demand. 

Pharma Forecasting Reimagined: Demand & GTN on a Common Platform

Explored how leading pharma manufacturing teams are modernizing their forecasting approach using Enterprise Performance Management (EPM) platforms.

Watch on-demand

From biotech startups to Fortune 100 pharma companies, Argano provides what's needed to help clients forecast net revenue with confidence, optimize accruals, and protect margins with audit-defensible precision. Let’s assess your GTN readiness together. 

Assess your GTN readiness

More insights